Reduced-toxicity conditioning regimen with busulfan, fludarabine, rATG, and 400 cGy TBI in pediatric patients undergoing hematopoietic stem cell transplant for high-risk hematologic malignancies.

Autor: Rossoff J; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Jacobsohn D; Children's National Medical Center, Washington, District of Columbia., Kwon S; Stanley Manne Children's Research Institute, Chicago, Illinois., Kletzel M; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Duerst RE; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Tse WT; University of Louisville, Louisville, Kentucky., Schneiderman J; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Chaudhury S; Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2021 Aug; Vol. 68 (8), pp. e29087. Date of Electronic Publication: 2021 May 22.

Comparison of Tc-99 measurement of glomerular filtration rate vs. calculated creatinine clearance to assess renal function pretransplant in pediatric patients undergoing hematopoietic stem cell transplantation.

Autor: Kletzel, M.¹ mkketzel@northwestern.edu, Pirich, L.¹, Haut, P.¹, Cohn, R. A.²

Publikováno v: Pediatric Transplantation. Oct2005, Vol. 9 Issue 5, p584-588. 5p.

Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Autor: Bognàr T; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands. Electronic address: t.bognar-2@umcutrecht.nl., Bartelink IH; Amsterdam University Medical Center, Location VUmc, Amsterdam, the Netherlands., Egberts TCG; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands., Rademaker CMA; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands., Versluys AB; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Slatter MA; Paediatric Haematopoietic Stem Cell Transplant Unit, Great North Children's Hospital, Newcastle upon Tyne, United Kingdom & Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Kletzel M; Stem Cell Transplant Program, Ann & Robert Lurie Children's Hospital/Northwestern University, Chicago, Illinois., Nath CE; Children's Hospital at Westmead, Sydney, New South Wales, Australia., Cuvelier GDE; Pediatric Blood and Marrow Transplantation, CancerCare Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada., Savic RM; Departments of Allergy/Immunology/Bone Marrow Transplantation, Clinical Pharmacy, or Bioengineering & Therapeutic Sciences of the University of California San Francisco (UCSF), San Francisco, California., Dvorak C; Division of Pediatric Allergy/Immunology/Bone Marrow Transplantation, University of California San Francisco (UCSF), San Francisco, California., Long-Boyle JR; Department Clinical Pharmacy and Division of Pediatric Allergy/Immunology/Bone Marrow Transplantation, University of California San Francisco (UCSF), San Francisco, California., Cowan MJ; Department Clinical Pharmacy and Division of Pediatric Allergy/Immunology/Bone Marrow Transplantation, University of California San Francisco (UCSF), San Francisco, California., Bittencourt H; Transplant and Cell Therapy Program. Hematology-Oncology Division, CHU Sainte-Justine, University of Montreal, Montreal, Quebec, Canada., Bredius RGM; Department of Pediatrics, Willem Alexander Children's Hospital, Leiden University Medical Center, Leiden, The Netherlands., Güngör T; Division of Stem Cell Transplantation and Children`s Research Center (CRC), University Children`s hospital Zürich, Switzerland., Shaw PJ; Blood Transplant and Cell Therapies Program, The Children's Hospital at Westmead, Sydney, NSW Australia, Clinical Professor, Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia., Ansari M; Cansearch Research Platform in Pediatric Oncology and Hematology, Faculty of Medicine, Department of Pediatrics, Gynecology and Obstetrics, University of Geneva, Geneva, Switzerland; Division of Pediatric Oncology and Hematology, Department of Women, Child and Adolescent, University Geneva Hospitals, Geneva, Switzerland., Hassan M; ECM, KFC, Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden., Krajinovic M; Centre de Cancérologie Charles-Bruneau Centre de recherche - Hôpital Sainte-Justine Montréal, Montréal, Québec, Canada., Hempel G; University of Münster, Münster, Germany., Marktel S; Stem Cell Program, IRCCS San Raffaele Scientific Institute, Milan, Italy., Chiesa R; Great Ormond Street, Hospital for Children London, United Kingdom & Stem Cell Program, IRCCS San Raffaele Scientific Institute, Milan, Italy., Théoret Y; Clinical Pharmacology Laboratory, OPTILAB and Research Center, CHU Sainte-Justine Montréal, Montreal, Québec, Canada., Lund T; Division of Pediatric Blood and Marrow Transplantation, Masonic Children's Hospital, University of Minnesota, Minneapolis, Minnesota., Orchard PJ; Division of Pediatric Blood and Marrow Transplantation, Masonic Children's Hospital, University of Minnesota, Minneapolis, Minnesota., Wynn RF; The Royal Manchester Children's Hospital, Manchester, United Kingdom., Boelens JJ; Stem Cell Transplantation and Cellular Therapies, Memorial Sloan-Kettering Cancer Center, New York, New York., Lalmohamed A; Department of Clinical Pharmacy, University Medical Center Utrecht/Wilhelmina Children's Hospital, Utrecht, the Netherlands.

Publikováno v: Transplantation and cellular therapy [Transplant Cell Ther] 2022 Apr; Vol. 28 (4), pp. 196-202. Date of Electronic Publication: 2022 Jan 19.

Gene Therapy in Patients with Transfusion-Dependent ß-Thalassemia

Autor: Thompson AA, Walters MC, Kwiatkowski J, Rasko JEJ, Ribeil JA, Hongeng S, Magrin E, Schiller GJ, Payen E, Semeraro M, Moshous D, Lefrere F, Puy H, Bourget P, Alessandra Magnani, Caccavelli L, Diana JS, Suarez F, Monpoux F, Brousse V, Poirot C, Brouzes C, Meritet JF, Pondarré C, Beuzard Y, Chrétien S, Lefebvre T, Teachey DT, Anurathapan U, Ho PJ, von Kalle C, Kletzel M, Vichinsky E, Soni S, Veres G, Negre O, Ross RW, Davidson D, Petrusich A, Sandler L, Asmal M, Hermine O, De Montalembert M, Hacein-Bey-Abina S, Blanche S, Leboulch P, Cavazzana M

Publikováno v: NEW ENGLAND JOURNAL OF MEDICINE
r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu
Universidad de las Islas Baleares

BACKGROUND: Donor availability and transplantation-related risks limit the broad use of allogeneic hematopoietic-cell transplantation in patients with transfusion-dependent ß-thalassemia. After previously establishing that lentiviral transfer of a m

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::7922b9dd3a69e3d6a2c01ff4b54c8f63
http://fundanet.fsjd.org/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=21069

Monosomy 7 associated with pediatric acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS): successful management by allogeneic hematopoietic stem cell transplant (HSCT).

Autor: Trobaugh-Lotrario, A. D.¹, Kletzel, M.², Quinones, R. R.¹, McGavran, L.¹, Proytcheva, M. A.², Hunger, S. P.³, Malcolm, J.¹, Schissel, D.¹, Hild, E.¹, Giller, R. H.¹ Giller.Roger@tchden.org

Publikováno v: Bone Marrow Transplantation. Jan2005, Vol. 35 Issue 2, p143-149. 7p.